This is a realistic
rerating case, not a moonshot. The upside comes from converting
backlog, winning more regulated enterprises, and shifting monetization from human seats toward committed AI usage and workflow value. The multiple can improve because today's valuation still discounts seat compression and execution risk, but the stock likely remains below best-in-class software leaders until
outcome-based pricing and trust-led differentiation are proven.